Interestingly, however, moderately reducing ATIC activity in adult mice with a specific inhibitor is beneficial, leading to an increase in AICAR and AMP-activated kinase (AMPK) activity, ameliorating metabolic syndrome phenotypes (Asby et al. 2015). The gene discussed is ATIC; the disease is metabolic syndrome.